{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-054952","form_type":"8-K","ticker":"IXHL","cik":"0001873875","company_name":"Incannex Healthcare Inc.","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.324433+00:00","generated_at":"2026-05-19T05:13:16.502014+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Incannex Healthcare forms 50:50 JV with Mind Medicine Australia for psychedelic therapy clinic","bullets":["JV creates 'Mind Medicine Australia Clinics' to operate a clinic in Melbourne.","JV aims to reduce treatment costs and more than triple patient capacity for PTSD and depression.","Patient intake expected to begin shortly in response to strong early demand.","MMA led 2023 regulatory rescheduling of psilocybin and MDMA for clinical use in Australia.","Incannex CEO cites alignment with long-term shareholder value and commercialization model."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-054952","json":"https://secwatch.observer/filing/0001213900-25-054952.json","markdown":"https://secwatch.observer/filing/0001213900-25-054952.md","text":"https://secwatch.observer/filing/0001213900-25-054952.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025054952/0001213900-25-054952-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025054952/ea0245972-8k_incannex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T05:13:16.502014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}